Advertisement
Advertisement

EXEL

EXEL logo

Exelixis Inc

53.00
USD
Sponsored
-0.13
-0.24%
Jun 15, 16:00 UTC -4
Closed
exchange

Pre-Market

52.44

-0.56
-1.07%

EXEL Earnings Reports

Positive Surprise Ratio

EXEL beat 34 of 42 last estimates.

81%

Next Report

Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$646.01M
/
$0.78
Implied change from Q1 26 (Revenue/ EPS)
+5.76%
/
-1.27%
Implied change from Q2 25 (Revenue/ EPS)
+13.68%
/
+20.00%

Exelixis Inc earnings per share and revenue

On May 05, 2026, EXEL reported earnings of 0.79 USD per share (EPS) for Q1 26, beating the estimate of 0.71 USD, resulting in a 10.07% surprise. Revenue reached 610.81 million, compared to an expected 617.30 million, with a -1.05% difference. The market reacted with a +9.64% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.78 USD, with revenue projected to reach 646.01 million USD, implying an decrease of -1.27% EPS, and increase of 5.76% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Exelixis Inc reported EPS of $0.79, beating estimates by 10.07%, and revenue of $610.81M, -1.05% below expectations.
The stock price moved up 9.64%, changed from $44.42 before the earnings release to $48.70 the day after.
The next earning report is scheduled for Jul 27, 2026.
Based on -- analysts, Exelixis Inc is expected to report EPS of $0.78 and revenue of $646.01M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement